Clinical Trial Update: A Study of LUMIGAN® RC in the Clinical Setting [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for LUMIGAN RC in glaucoma and ocular hypertension; the study has completed and results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• LUMIGAN RC (bimatoprost/timolol)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Primary Open Angle, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2013-09-26